Market closed
Lensar/$LNSR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Lensar
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
Ticker
$LNSR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
140
Website
Lensar Metrics
BasicAdvanced
$166M
-
-$2.73
0.62
-
Price and volume
Market cap
$166M
Beta
0.62
52-week high
$17.31
52-week low
$9.78
Financial strength
Current ratio
2.798
Quick ratio
1.918
Long term debt to equity
11.209
Total debt to equity
14.019
Management effectiveness
Return on assets (TTM)
-7.64%
Return on equity (TTM)
-95.42%
Valuation
Price to revenue (TTM)
3.027
Price to book
33.7
Price to tangible book (TTM)
-131.08
Price to free cash flow (TTM)
-66.616
Growth
Revenue change (TTM)
26.87%
Earnings per share change (TTM)
107.97%
3-year revenue growth (CAGR)
15.79%
3-year earnings per share growth (CAGR)
9.25%
Lensar News
AllArticlesVideos
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR
Business Wire·1 week ago
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders
Business Wire·2 weeks ago
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Lensar stock?
Lensar (LNSR) has a market cap of $166M as of April 05, 2025.
What is the P/E ratio for Lensar stock?
The price to earnings (P/E) ratio for Lensar (LNSR) stock is 0 as of April 05, 2025.
Does Lensar stock pay dividends?
No, Lensar (LNSR) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next Lensar dividend payment date?
Lensar (LNSR) stock does not pay dividends to its shareholders.
What is the beta indicator for Lensar?
Lensar (LNSR) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.